Embecta Corp. (EMBC) vs Pro-Dex, Inc. (PDEX)
Embecta Corp. and Pro-Dex, Inc. are both Medical Instruments & Supplies companies. Embecta Corp. is the larger, with a market value of $316.2M against $233.9M — 1.4× the size. Embecta Corp. trades at the lower P/E: 4.0× against 17.0×. Pro-Dex, Inc. grew revenue faster over the last twelve months: 16.5% against −7.60%. Pro-Dex, Inc. has the higher net margin (17.6% vs 8.59%) and the lower return on invested capital (15.8% vs 21.4%). Across the 21 metrics below, Embecta Corp. leads on 12 and Pro-Dex, Inc. on 9.
Valuation
Profitability
| Metric | EMBC | PDEX | Medical Instruments & Supplies median |
|---|---|---|---|
| Gross margin | 59.03% | 31.38% | 54.62% |
| Operating margin | 21.94% | 16.75% | 1.64% |
| Net margin | 8.59% | 17.62% | 0.00% |
| Free cash flow margin | 17.15% | 8.72% | 1.61% |
| Return on equity | (13.65%) | 32.43% | 0.00% |
| Return on assets | 7.22% | 20.14% | 0.00% |
| Return on invested capital | 21.44% | 15.75% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack